Many epidemiological studies have shown that a high consumption of fruits and vegetables is associated with a reduced risk of CVD and other chronic diseases(Reference Zhang, Shu and Xiang1–Reference van Duijnhoven, Bueno-De-Mesquita and Ferrari3). CVD is responsible for about half (48 %) of all deaths annually in Europe and is the major cause of death in men and women in the UK(Reference Allender, Scarborough and Peto4). Endothelial dysfunction is a central feature in the early development of CVD, and impairment of endothelium-dependent vasodilation has been shown to precede structural atherosclerotic lesions(Reference McLenachan, Williams and Fish5). The vascular endothelium displays systemic characteristics, which enables non-invasive measurements of peripheral circulation to be used as an indicator of the condition of the coronary arteries(Reference Lieberman, Gerhard and Uehata6). Laser Doppler imaging coupled with iontophoresis (LDI) is one such method of investigating the vasodilation of the peripheral microvasculature by delivering vasodilator agents across the skin under the influence of an applied electrical field(Reference Anderson, Uehata and Gerhard7). Acetylcholine is administered at the anode and tests endothelial function via its vasodilator action of binding to muscarinic receptors on endothelial cells, subsequently generating NO via endothelial NO synthase (eNOS), thereby acting as an ‘endothelium-dependent’ vasodilator. A NO donor, sodium nitroprusside, is administered at the cathode and acts as an ‘endothelium-independent’ vasodilator, which acts as a control to test the integrity of vascular smooth muscle. Many fruits, vegetables and their juices contain polyphenolic flavonoid compounds(Reference Hollman and Arts8, Reference Tomas-Barberen and Clifford9) that have been shown to increase eNOS activity in cell and animal studies at physiological concentrations(Reference de Nigris, Williams-Ignarro and Sica10–Reference Gomez-Guzman, Jimenez and Sanchez15). In addition, there is a growing body of evidence that supports the beneficial impact of chronic fruit and vegetable consumption(Reference Poreba, Poreba and Jedrychowska16–Reference McCall, McGartland and McKinley18) and isolated flavonoids(Reference Enseleit, Sudano and Périat19, Reference Zhu, Xia and Yang20) on improvements in measures of vascular function. However, the acute in vivo vascular response to fruit and vegetable consumption in human subjects is very limited(Reference Bondonno, Yang and Croft21) and has not been adequately assessed.
Oxidation of LDL has been recognised as an early stage in the development of atherosclerosis leading to CVD(Reference Lapointe, Couillard and Lemieux22–Reference Heinonen, Rein and Satue-Gracia25). Many studies have reported the antioxidant effects of phytochemicals in fruits and vegetables, which include the retardation of the susceptibility of LDL to oxidation in vitro and in vivo (Reference Lapointe, Couillard and Lemieux22–Reference Safari and Sheikh24, Reference Manach, Scalbert and Morand26). Plant foods contain many components that could contribute to significant health benefits, including vitamins, fibre, carotenoids, sulphur compounds, nitrate and organic acids, as well as a wide variety of phenolic phytochemicals(Reference Manach, Scalbert and Morand26–Reference Chuang, Norat and Murphy29). Compounds in the latter class may contribute to benefits by reducing oxidative stress(Reference Manach, Williamson and Morand27), by regulating enzymes involved in phase 2 metabolism, as well as by other mechanisms. The beneficial components listed earlier are also retained in many fruit and vegetable juices and purée products(Reference Aviram, Dornfeld and Rosenblat30–Reference May32). Research has shown that fruit and vegetable juices also have a protective effect against CVD risk(Reference Morand, Dubray and Milenkovic17, Reference Ruxton, Gardner and Walker33). In the UK, the average adult consumes less than the recommended minimum of five 80 g portions of fruits and vegetables per d(34), but there has been a continued increase in fruit juice and liquidised/puréed product consumption in the UK(35), and these products represent an important source of micronutrients. The aim of the present study was to investigate the acute effects of the consumption of a concentrated fruit and vegetable purée-based drink on vascular function, antioxidant status and plasma concentrations of beneficial phytochemicals and vitamin C, which could contribute to a reduction in the risk of chronic diseases, such as CVD.
Experimental methods
Study population
A total of twenty-four subjects (twenty males and four females), aged between 30 and 70 years, completed the study. The subjects were recruited from the University of Reading and general public around the Reading area, and were selected if they met the study criteria of no known liver disease, diabetes mellitus or a diagnosed mycocardial infarction; no gall bladder problems or abnormalities of fat metabolism; no subjects on weight-reducing diets or taking dietary supplements; no vigorous exercise or excess consumption of alcohol; BMI < 30 kg/m2; blood pressure < 150/90 mmHg and Hb >125 g/l. All study subjects had basic anthropometric measurements recorded, and fasting blood was taken and analysed for liver function status, lipid levels, fasting glucose and a measure of potential alcohol abuse. A total of twenty-five subjects were required to be recruited to detect a 10 % difference in acetylcholine vasodilatory response measured by LDI based on the present data for intra-subject reproducibility response (within-day and between-day variation, both 12 %), with P< 0·05, 80 % power and an allowance for a 10 % drop-out. The present study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving human subjects were assessed by the University of Reading Research Ethics Committee who gave a favourable ethical opinion for conduct. Each subject gave written informed consent before participating. The registration number for clinical trials is ISRCTN36287115.
Study design
The study was a randomised, single-blind, controlled, crossover, acute postprandial test meal study. The subjects were randomly assigned to either the fruit and vegetable purée-based drink (FVPD) or the control drink. The subjects consumed a low-flavonoid diet for a 5 d period preceding the study day. On the study day, a flexible cannula was inserted into the forearm and blood samples taken at baseline and at twelve additional time points after consumption of the relevant drink, eight samples 30 min apart followed by four samples 1 h apart. Urine was collected before the drink was consumed and then at 2 h intervals for 8 h of the study day. LDI was used to record a real-time measure of vascular reactivity for two baseline measurements and five measurements following drink consumption, all at 90 min intervals. The whole procedure was repeated with the other intervention drink after a 4-week washout.
Intervention drinks
Subjects were asked to consume 400 ml FVPD (Vie Shots; Unilever Bestfoods) or 400 ml fruit-flavoured cordial (Robinsons Lemon Barley Water; Robinsons Limited), which was matched for sugar composition and diluted with low-nitrate mineral water (The Buxton Mineral Water Company Limited). The FVPD was a fruit and vegetable drink made from 800 g fruit and vegetables in the form of concentrated juices and purées, which was composed of apple (56 %), carrot (29 %) and strawberry (8 %). The nutrient composition of the drinks is shown in Table 1.
GAE, gallic acid equivalents.
* Adapted from George et al. (Reference George, Niwat and Waroonphan65)
Fruit and vegetable purée-based drink antioxidant components
FVPD extracts were prepared by extraction with acidified methanol(Reference Markakis36). Total phenolic compounds were determined by the Folin–Ciocalteu method(Reference Singleton, Orthofer and Lamuela-Raventos37), and flavonoid content and composition were determined by HPLC(Reference Safari and Sheikh24). The polyphenol content of the FVPD was determined by the method of Garcia-Macias et al. (Reference Garcia-Macias, Ordidge and Vysini38). Aqueous antioxidant activity was assessed by the oxygen radical absorbance capacity method(Reference Ou, Hampsch-Woodill and Prior39). A volume of FVPD extract containing 0·5 μm-gallic acid equivalents, determined by the Folin–Ciocalteu method, was incubated with isolated LDL containing 100 μg protein in the assay.
Anthropometric measurements
Measurements of height, weight, BMI and blood pressure were recorded at the start of each of the two study days.
Plasma collection and analysis
Blood samples were collected via syringe from a cannula and transferred to citrate, EDTA and lithium heparin vacutainer tubes. The tubes were immediately wrapped in foil and kept on ice for transport to the laboratory. Following centrifugation at 4°C at 3000 rpm, plasma was aliquotted into separate cryogenic vials for storage at − 80°C. Analysis did not commence until the intervention study was completed, and all samples from each subject were analysed within one batch to reduce inter-batch variation.
Analyses of plasma TAG, total and HDL-cholesterol, NEFA and glucose were performed using an Instrument Laboratory ILAB 600 autoanalyser and standard kits (Instrumental Laboratories Limited). Appropriate sero-normal, low and high quality control standards (Instrument Laboratories Limited) were included in all batches. Insulin was assessed by ELISA (Dako Cytomation; Ely) with in-house pooled plasma controls in each batch.
Plasma samples for ascorbic and uric acid analysis were treated with 5 % metaphosphoric acid (1:1, v/v) and stored at − 80°C prior to analysis by HPLC with UV detection(Reference Liau, Lee and New40, Reference Ross41). Total nitrate/nitrite was measured using an ELISA kit (Active Motif; Rixensart) based on the Greiss reaction(Reference Green, Wagner and Glogowski42) in plasma, FVPD and the control drink.
The ferric-reducing antioxidant power (FRAP) of plasma was determined using the method of Benzie & Strain(Reference Benzie and Strain43), adapted for use with ninety-six-well microtitre plates(Reference Bub, Watzl and Abrahamse44). A Genios spectrophotometer (Tecan Limited) was used to measure the absorbance at 593 nm. This method was used to estimate aqueous antioxidants. The method for LDL isolation and assessment of oxidative stability was based on that of Leigh-Firbank et al.(Reference Leigh-Firbank, Minihane and Leake45). Concentrations of 50 μg of LDL protein/ml and 5 μm-CuSO4 were used for oxidation at pH 7·4. The formation of conjugated dienes (the breakdown products of lipid peroxidation) was monitored at 234 nm, 37°C every 2 min for 3 h using a Perkin-Elmer Lambda bio 20 UV/VIS Spectrometer(Reference Esterbauer, Striegl and Puhl46).
Plasma (300 μl) was extracted four times with 0·5 ml of ethyl acetate by vortexing for 1 min after addition of 100 μl of 5 m-HCl. The mixture was then centrifuged at 13 200 rpm for 10 min, and the top layer removed. The ethyl acetate extracts were dried and derivatised by the addition of 200 μl of N, O-bis(trimethylsilyl) trifluoroacetamide+trimethylchlorosilane and heated at 70°C for 4 h(Reference Zhang and Zuo47). An Agilent Technologies Model GC 6890N (G1530N) gas chromatograph coupled with an Agilent 5975 series Inert XL mass selective detector and a CTC analysis system autosampler were used for analyses. Samples (2·0 μl) were analysed on a 30 m, 0·25 mm inner diameter, 0·50 μm, DB-5-fused silica capillary column (Agilent Technologies), with temperature programming from 80°C (1 min) increasing up to 220°C at a rate of 10°C/min and from 220 to 310°C at a rate of 10°C/min and held for 6 min. Electron-impact mass spectra were recorded with ionisation energy of 70 eV. o-Phthalic acid was used as an internal standard.
Urinary creatinine, hippuric and phenolic acids
Analysis of urinary creatinine was performed using an Instrument Laboratory ILAB 600 autoanalyser. Urinary hippuric acid was measured as an indicator of polyphenol metabolism(Reference Rechner, Kuhnle and Bremner48) and determined by the extraction method of Mohsen et al. (Reference Mohsen, Marks and Kuhnle49) and analysed by HPLC by adapting the methods of Felgines et al. (Reference Felgines, Talavera and Gonthier50) and Kay et al. (Reference Kay, Mazza and Holub51).
Laser Doppler imaging with iontophoresis
Subjects were in a supine position, in a quiet room at an ambient temperature of 22 ± 1°C for all measures. Two ION6 Perspex chambers (Moor Instruments Limited) with an internal platinum wire electrode were placed on the volar aspect of the forearm and attached to the skin using adhesive discs (MIC-1AD; Moor Instruments Limited) and connected to a MIC2 iontophoresis controller (Moor Instruments Limited). Skin temperature was recorded at the time of measurement. Acetylcholine chloride (2·5 ml, 1 %; Sigma-Aldrich) in 0·5 % NaCl solution was placed in the anodal chamber and 2·5 ml of 1 % sodium nitroprusside (Sigma-Aldrich) in 0·5 % NaCl solution was placed in the cathodal chamber. Circular glass coverslips were placed over each chamber to prevent loss of solutions. Current delivery was controlled by laser Doppler imager Windows software 5.1 (Moor Instruments Limited). Measurement of skin perfusion was carried out using a moorLDI2-IR laser Doppler imager (Moor Instruments Limited). The scanner head was positioned 30 cm above the chambers. The laser light was directed by a moving mirror in a raster fashion over both chambers. A total of ten repeat scans were taken, the first with no current to act as a control, then two scans at 10 μA, two at 20 μA, two at 30 μA and one at 40 μA to give a total charge of 8 mC, the final two scans were measured without any current. The area under the flux v. time curve over the ten scans was deemed to indicate the microvascular response.
Statistical analyses
All statistical analyses were performed using SPSS 13.0 for Microsoft Windows (SPSS Inc.). The data were checked for normality using the Shapiro–Wilk test, as the number of subjects was less than fifty. Those data that were not normally-distributed were log transformed and reassessed. A repeated-measures ANOVA was used to detect significant differences between treatment groups with Bonferroni correction to reduce the likelihood of chance findings from multiple comparisons. A value of P ≤0·050 was used to define significance and a 95 % CI. The data presented in tables and graphs are displayed as means with their standard errors, unless otherwise stated.
Results
Antioxidant components of fruit and vegetable purée-based drink
The antioxidant components of the FVPD are listed in Table 1. The FVPD contained a high concentration of flavonoids, with 400 ml of the FVPD supplying 768 mg of total phenolics (gallic acid equivalents) including 100 mg of anthocyanins. The control drink contained only 44 mg of total phenolics (gallic acid equivalents) with no anthocyanins. The FVPD had a high antioxidant capacity when assessed by the oxygen radical absorbance capacity assay (6702 μm Trolox equivalents).
Anthropometric data
The baseline anthropometric data for the subjects are shown in Table 2. There was no change in weight, BMI or blood pressure between study days (data not shown).
BP, blood pressure.
Biochemical data
There was a significant time by treatment effect (P< 0·001) and a significant increase in plasma ascorbic acid concentration following FVPD consumption at all time points from 60 min after ingestion, reaching a maximum value approximately 120 min after consumption. The plasma uric acid concentration did not change significantly (Table 3). There was a significant increase in oxidative stability determined by the FRAP assay after FVPD consumption, as shown in Fig. 1 (time by treatment, P= 0·030). The peak FRAP response occurred 60 min after FVPD consumption (P= 0·003). It was observed that there was a near significant attenuation in the reduction in the postprandial LDL oxidation lag phase response (time by treatment, P= 0·068) after the FVPD compared with the control drink, with a significant difference in LDL oxidation lag phase between treatments at 60 min after FVPD consumption (P= 0·016; Fig. 2). There was no correlation between the concentration of either plasma vitamin C or uric acid with plasma antioxidant capacity assessed by the FRAP and LDL oxidation assays (data not shown).
* Mean values were significantly different from control (P< 0·01).
There was a significant time by treatment interaction (P= 0·03) in the plasma concentration of salicylic acid, with a significant increase from 1 to 5 h after FVPD consumption (Table 4, P< 0·0001). Plasma benzoic acid concentration tended to increase at 2 h after FVPD consumption and almost reached statistical significance at 6 h (Table 4, P= 0·07). The benzoic acid concentration in the FVPD group remained higher than observed after consumption of the control drink throughout the intervention period. Plasma p-hydroxyphenylacetic acid and 3-(4-hydroxy phenyl)-2-hydroxypropanoic acid concentrations remained higher than the response to the control drink throughout the 8 h intervention period (Table 4). Both compounds peaked 90 min after FVPD consumption, but only p-hydroxyphenylacetic acid reached a maximum that was significantly higher than the control (Table 4, P= 0·01). After consuming the FVPD, the urinary concentration of vanillic acid, p-hydroxybenzoic acid and ferulic acid remained higher than the control treatment throughout the intervention period (Fig. 3), the mean peak concentration occurred after 4 h for vanillic and p-hydroxybenzoic acid (P< 0·001 and 0·04, respectively) as shown in Fig. 3(a) and (b). Ferulic acid was only found in urine after subjects consumed the FVPD, and the concentration peaked after 2 h and remained constant until 6 h before reducing. There was a highly significant time by treatment effect (P< 0·0001) in the plasma concentration of hippuric acid, with a significant increase from 3 to 8 h after FVPD consumption only (Table 4). There was also a significant time by treatment effect (P= 0·008) in the urinary excretion of hippuric acid, with a significant increase at 360 and 480 min after FVPD consumption (P= 0·0001 and 0·010, respectively) as shown in Fig. 3(d).
* Mean values were significantly different from control (P< 0·01 after post hoc tests).
A significant time by treatment effect was observed for the glucose and insulin response (Table 3, P= 0·019 and 0·003, respectively), with a significantly lower peak concentration after consumption of the FVPD compared to the sugar-matched control (P= 0·004 and 0·029, respectively). There was no effect of FVPD consumption on plasma TAG, total or HDL-cholesterol or NEFA (data not shown). There was a significant time by treatment interaction (P< 0·001) and a significant increase in total plasma nitrate/nitrite concentration following FVPD consumption at all time points after ingestion (Fig. 4).
Laser Doppler imaging with iontophoresis
The endothelium-dependent vasodilation response to acetylcholine is shown in Fig. 5. There was a trend towards increased vasodilation following FVPD consumption throughout the day, which almost reached statistical significance (P= 0·061).
Discussion
The present study is the first to investigate the effects of an acute ingestion of fruits and vegetables, in the form of 400 ml of a purée-based drink, on vascular reactivity and plasma and urine phytochemical composition. The FVPD contained significant levels of vitamin C and polyphenols from the fruit sources, including anthocyanins, other flavonoids and phenolic acids. The present study is one of a few studies that have investigated the effect of an acute ingestion of polyphenol-rich drink on postprandial LDL oxidation. A major finding of the present study was that the susceptibility of LDL to oxidation increased throughout the 8 h of the intervention period after subjects fasted overnight and consumed either the FVPD or control. A fall in the lag phase time in subjects who had fasted for at least 12 h was also reported by Hodgson et al. (Reference Hodgson, Puddey and Croft52), who found that LDL isolated at 60 min after consumption of water or water-containing caffeine had lag phases that were shorter than the baseline values. However, the acute consumption of the FVPD significantly increased the lag phase compared to control after 60 min for all subjects (P= 0·016) and the lag phase remained longer than control over a 4 h period. The increase in lag phase cannot be due to carotenoid components, because most of the increase in plasma carotenoids occurs after more than 2 h(Reference Brown, Ferruzzi and Nguyen53). There was a significant increase in plasma ascorbic acid following FVPD consumption, with a maximum concentration reached at 150–180 min, indicating that the ascorbic acid in the FVPD was effectively absorbed. An increase in plasma oxidative stability, assessed by the FRAP assay from 60 to 180 min, suggested that the antioxidant components of the FVPD, including ascorbic acid and flavonoids, increased the antioxidant capacity. There was no effect of treatment on plasma uric acid, which was not surprising as the control drink was matched for sugar composition, which was necessary as previously it has been shown that fructose increases plasma uric acid(Reference Lotito and Frei54). Caccetta et al. (Reference Caccetta, Croft and Beilin55) found a significant increase in plasma uric acid over 4 h, with a peak at 60 min after the subjects consumed 350 ml of red wine, but wine consumption had no effect on LDL oxidation.
In the present study hippuric acid was the main flavonoid metabolite found in plasma and urine. The result was comparable to previously reported studies, after consumption of phenolic compounds such as flavanols, quercetin or chlorogenic acid(Reference Manach, Scalbert and Morand26, Reference Rechner, Kuhnle and Bremner48, Reference Olthof, Hollman and Buijsman56, Reference Valentova, Stejskal and Bednar57). When these compounds reach the colon, they can be converted to valerolactone and then to phenolic acids by the action of gut microflora, which are then converted to benzoic acid by β oxidation in the liver and benzoic acid is conjugated with glycine to form N-benzoylglycine or hippuric acid, which can be absorbed or excreted in urine(Reference Rechner, Kuhnle and Bremner48, Reference Olthof, Hollman and Buijsman56). Valentova et al. (Reference Valentova, Stejskal and Bednar57) observed that after subjects consumed 1200 mg of dried cranberry juice/d for 8 weeks (estimated daily intake of 35 mg total phenolics), the major metabolite found in the urine was hippuric acid, which was present at a significantly higher concentration than the control. Additionally, the serum levels of advanced protein oxidation products were decreased at the end of the intervention. However, in contrast, no correlation between plasma/urinary hippuric acid and plasma antioxidant status was observed in the present study (data not shown). Hippuric acid has no antioxidant activity, due to the absence of a phenolic hydroxyl group in the molecule. In support of this, no correlation was observed between flavonoid metabolites in plasma and urine with antioxidant status after consumption of the FVPD. Plasma antioxidant status assessed by LDL oxidation and by the FRAP assay peaked at 60 min after consumption of the FVPD. The increase in oxidative stability at 60 min is expected to be mainly due to the protection of LDL by the increased plasma vitamin C concentration prior to isolation of the LDL. Hippuric acid reaching a peak at 5 and 6 h in plasma and urine, respectively. The delayed appearance of hippuric acid reflected the fact that this compound was formed in the colon due to bacterial metabolism and subsequently absorbed and excreted in the plasma and urine, respectively(Reference Manach, Scalbert and Morand26, Reference Rechner, Kuhnle and Bremner48, Reference Olthof, Hollman and Buijsman56, Reference Valentova, Stejskal and Bednar57). Epicatechin was the major flavonoid detected in the FVPD, followed by anthocyanins and caffeic acid (Table 1). However, apart from hippuric acid, which is the major metabolite of flavanols and hydroxycinnamates, other metabolites such as glucuronides, sulphates and o-methylates, in addition to anthocyanins, were not detected in the plasma or urine samples. The major metabolites detected were phenolic acids. These are secondary metabolites derived from the biotransformation of colonic microflora. The method used to analyse plasma was relatively insensitive in detecting intact flavonoid derivatives.
Several studies have investigated the effect of acute consumption of foods on Cu-catalysed LDL oxidation. Natella et al. (Reference Natella, Nardini and Belelli58) reported that acute consumption of a cup of coffee significantly reduced the susceptibility of LDL to oxidation by increasing the lag phase of LDL isolated from blood removed at 30 and 60 min after consumption. Hodgson et al. (Reference Hodgson, Puddey and Croft52) found no significant effect of the acute consumption of green tea, black tea and water containing 180 mg caffeine on LDL oxidation lag phase and total antioxidant capacity of samples isolated 60 min after consumption. Miyagi et al. (Reference Miyagi, Miwa and Inoue59) reported that acute consumption of red wine containing 433 mg of total phenolics caused a significant increase in the lag phase time of samples isolated 1 and 2 h after consumption. However, consumption of red grape juice containing 511 mg of total phenolics had no effect. Caccetta et al. (Reference Caccetta, Croft and Beilin55) reported findings that contradict the latter study, with no effect on the susceptibility of LDL to oxidation after acute consumption of red wine containing 700 mg of total polyphenols. Another postprandial study investigated the effect of consuming olive oil containing 2·7, 164 and 366 mg/kg of phenolic compounds on LDL oxidation. The results showed that only the consumption of 366 mg/kg olive oil had an effect, retarding LDL oxidation by 9·5 and 15·2 % in LDL isolated from blood removed 2 and 6 h, respectively, after consumption of olive oil(Reference Covas, de la Torre and Farre-Albaladejo60). Consequently, the effect of polyphenol-rich foods on the susceptibility of LDL to oxidation in acute interventions depends on the nature and amount of polyphenols in the food, as well as on other variables. The fall in oxidative stability of LDL isolated from both test and control groups after baseline may be due to the effects of fasting. However, absorption or formation of flavonoid metabolites in the plasma of subjects may be the reason for the increase in plasma antioxidant capacity due to the FVPD.
The present study also found that there was a significantly lower glucose and insulin peak concentration after consumption of the FVPD compared to the sugar-matched control. As the FVPD contained a mixture of purées and concentrated juices, this may have been due to the matrices of the fruit and vegetable particles slowing down the absorption of the sugars, whereas the sugars in the control drink were dissolved in mineral water. This highlights an additional benefit to puréed fruits and vegetables over juices that contain minimal food matrix components. There was a significant increase in total plasma nitrate and nitrite following FVPD consumption. The control drink was specifically diluted with Buxton mineral water that had the lowest nitrate content of all commercially available mineral waters. This was chosen to reduce any confounding effects of nitrate in the control, affecting vasodilation measured by LDI. Although the FVPD contained a minimal concentration of nitrate/nitrite from the fruits and vegetables (1·0 mg in 400 ml), the plasma concentrations of nitrate/nitrite at each time point after consumption of the FVPD were significantly higher than the expected concentration provided by the drink. The increase in plasma nitrate/nitrite was maintained throughout the day, whereas research has shown that the plasma nitrate concentration from the ingestion of dietary sources reaches a peak after approximately 60 min and then declines(Reference Hobbs, Kaffa and George28, Reference Wagner, Schultz and Deen61). Therefore, the increase in nitrate/nitrite following FVPD consumption could be due to flavonoid components within the drink increasing eNOS activity. In vitro studies have shown that flavonoids(Reference de Nigris, Williams-Ignarro and Sica10–Reference Elies, Cuinas and Garcia-Morales12) at physiological concentrations(Reference Nicholson, Tucker and Brameld13) can increase eNOS gene expression. The FVPD was particularly rich in ( − )-epicatechin (457 mg/400 ml) and this compound has been shown to increase eNOS activity(Reference Schroeter, Heiss and Balzer14, Reference Gomez-Guzman, Jimenez and Sanchez15) and endothelium-1 release(Reference Gomez-Guzman, Jimenez and Sanchez15). In support of these findings, acute consumption of epicatechin-rich apples and grapes (consumed as champagne) have been associated with beneficial effects on postprandial NO status and on in vivo vasodilation measured by LDI(Reference Vauzour, Houseman and George62) and flow-mediated dilation(Reference Bondonno, Yang and Croft21) in randomised control human studies. In addition, increased plasma NO and increased vasodilation have been reported after chronic consumption of fruits and vegetables, which may be due in part to flavonoids and/or other bioactive components(Reference Poreba, Poreba and Jedrychowska16–Reference McCall, McGartland and McKinley18). The significant increase in urinary hippuric acid at 360 and 480 min indicated that the flavonoid components of the FVPD were absorbed with metabolism into hippuric acid, which is a metabolite of several polyphenol compounds(Reference Rechner, Kuhnle and Bremner48, Reference Olthof, Hollman and Buijsman56).
The novel LDI results were encouraging. There was a trend towards increased endothelium-dependent vasodilation following ingestion of the FVPD compared to the control drink. The initial increase could be due to flavonoid components present in the FVPD increasing eNOS activity by scavenging superoxide(Reference Schroeter, Heiss and Balzer14), which may explain the increase in total plasma nitrate and nitrite found after FVPD consumption. The largest increase in vasodilation was observed at approximately 7·5 h after FVPD consumption, which could be attributed, at least in part, to methylated flavonoid metabolites from the small intestine(Reference Kuhnle, Spencer and Schroeter63). These metabolites have been shown to have an even greater ability to increase eNOS activity compared with the parent molecules by inhibiting endothelial NADPH oxidase, thereby reducing superoxide production(Reference Steffen, Gruber and Schewe64). There was no effect of the FVPD on plasma TAG, total and HDL-cholesterol or NEFA, but this was not unexpected as no fat meal had been given with the drinks.
Overall, the present study provides evidence that consumption of fruits and vegetables in the form of purée-based drinks acutely increases plasma ascorbic acid, total plasma nitrate and nitrite concentrations, oxidative stability of plasma assessed by the FRAP and ex vivo Cu-catalysed LDL oxidation. Increased concentrations of phenolic metabolites were detected in plasma and urine after consumption of the FVPD, and it was concluded that the increase in the oxidative stability of LDL and antioxidant capacity of plasma could be due to components in the FVPD such as phenolic acids, flavonoids and their metabolites. There was a trend towards increased endothelium-dependent vasodilation following FVPD consumption, which may be due to increased eNOS activity or increased NO sparing indicated by the increased plasma nitrate and nitrite. Purée-based fruit and vegetable drinks are suitable vehicles for micronutrient and phytochemical ingestion, which may contribute to CVD risk reduction.
Acknowledgements
The authors acknowledge funding from the University of Reading Research Endowment Trust Fund; the Royal Thai Government (Ministry of Science and Technology) and Chiangmai University, Thailand; the Food Standards Agency, UK and Unilever Bestfoods (Germany). The authors would like to thank the study participants for their involvement in the study, Jan Luff for her help with recruitment and Dr Anna Macready for her assistance in manuscript formatting. The authors have no conflict of interest. T. W. G. and J. A. L. prepared the manuscript. T. W. G., J. A. L. and M. H. G. designed the study. T. W. G. and C. N. conducted the study. T. W. G., S. W. and C. N. performed the analysis. J. A. L. had primary responsibility for the final content. All authors read and approved the final manuscript. Preliminary findings from the present study were presented at a Postgraduate Symposium during the Summer Meeting of the Nutrition Society 2008(Reference George, Niwat and Waroonphan65) and at the International Symposium II on Human Health Effects of Fruit and Vegetables: FAVHEALTH 2007(Reference George, Paterson and Niwat66).